The Flow Cytometry Shared Resource (FCSR) was established in 1985 as a UTHSCSA Shared Resource. In 1991, it was integrated into the Cancer Center Support Grant (CCSG) as a Cancer Center Shared Resource. The mission of the FCSR is to deliver high-throughput, multi-dimensional cell analysis and cell sorting using state-of-the-art equipment for Cancer Therapy &Research Center (CTRC) members. The FCSR jointly managed by CTRC and UTHSCSA. The FCSR operates at two locations;the Long campus and the Greehey campus in the newly built South Texas Research Facility (STRF ), with managing one cell sorter and one cell analyzer. The Long campus facility is located in 800 sq.ft. in room 5.044Vand houses a FACSAria and a SORP LSRII. The STRF site is located in 1,306sq.ft. (room 251). It houses a MoFlo Astrios and a FACSCalibur. FCSR services include multiparameter analysis and sorting of subpopulations of cells;cell cycle analysis and sorting;single cell cloning;measurements of nitric oxide, oxygen peroxide and free radicals, pH, Ca++ fluxes and fluxes of different vital dyes;study of mitochondrial damage;and determination of multiple activated caspases. Using the cytometry bead array (CBA) technology, quantification of multiple cytokines can be measured simultaneously. The FCSR actively offers consulting services ranging from experimental design, instrument training, and grant and manuscript writing (including preparing figures, method sections and budgets). FCSR personnel includes Dr. Benjamin Daniel, FCSR Director (13 years of experience). Dr. Vivienne Rebel, Scientific Advisor, (22 years of experience) and Karia Gorena, BS, Technical Director, the primary instrument operator (7 years of experience). This team uses their expertise to provide training to users in the forms of theory, on instrument, and technical support at cost-effective rates. During the last award year, FCSR services supported 23 peer-review funded and 20 non peer-review funded cancer center members, comprising 73% of the total shared resource usage. In addition, the FCSR services contributed to 48 cancer-related manuscripts during the current award period (2008-2013).

Public Health Relevance

The FCSR supports the research of CTRC members who investigate all aspects of cancer, including but not limited to, basic science studies into the mechanisms of tumorigenesis and clinical-based cancer studies including treatment-focused research such as testing novel anti-tumor drugs. The instrumentation in the FCSR and its highly qualified staff are vital to identifying and isolating the cells that are the focus of these studies, such as cancer stem cells, immune cells or microenvironment components.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RTRB-A (M3))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Health Science Center
San Antonio
United States
Zip Code
Zanotto-Filho, Alfeu; Dashnamoorthy, Ravi; Loranc, Eva et al. (2016) Combined Gene Expression and RNAi Screening to Identify Alkylation Damage Survival Pathways from Fly to Human. PLoS One 11:e0153970
Newcomb, Lisa F; Thompson Jr, Ian M; Boyer, Hilary D et al. (2016) Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort. J Urol 195:313-20
Ortiz, Carmen; Morales, Luisa; Sastre, Miguel et al. (2016) Cytotoxicity and Genotoxicity Assessment of Sandalwood Essential Oil in Human Breast Cell Lines MCF-7 and MCF-10A. Evid Based Complement Alternat Med 2016:3696232
Price, Douglas K; Chau, Cindy H; Till, Cathee et al. (2016) Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial. Cancer 122:2332-40
Zanotto-Filho, Alfeu; Masamsetti, V Pragathi; Loranc, Eva et al. (2016) Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis. Mol Cancer Ther 15:3000-3014
Sareddy, Gangadhara R; Li, Xiaonan; Liu, Jinyou et al. (2016) Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma. Sci Rep 6:24185
Sweeney, Shannon R; Kavanaugh, Arthur; Lodi, Alessia et al. (2016) Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis. RMD Open 2:e000289
Schenk, Jeannette M; Till, Cathee; Hsing, Ann W et al. (2016) Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial. Cancer Causes Control 27:175-82
Toledo, Rodrigo A; Qin, Yuejuan; Cheng, Zi-Ming et al. (2016) Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas. Clin Cancer Res 22:2301-10
Wu, Anqi; Dong, Qiaoxiang; Gao, Hui et al. (2016) Characterization of mammary epithelial stem/progenitor cells and their changes with aging in common marmosets. Sci Rep 6:32190

Showing the most recent 10 out of 853 publications